ARTV Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

PRME • United States

Prime Medicine, Inc.

3.99 USD

723.69M USD 1Y -44.5%

CTMX • United States

CytomX Therapeutics, Inc.

2.57 USD

560M USD 1Y -26.7%

SLDB • United States

Solid Biosciences Inc.

6.87 USD

736.64M USD 1Y +8.1%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

NGNE • United States

Neurogene Inc.

26.4 USD

528.3M USD 1Y +2.6%

ACHV • United States

Achieve Life Sciences, Inc.

7.41 USD

763.99M USD 1Y +108.4%

ODTX • United States

Odyssey Therapeutics, Inc.

19 USD

913.11M USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

149.0% p.a.

Max Drawdown (3Y)

-90.7%

Sharpe Ratio (3Y)

-0.17

Beta Factor

2.41

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 2.41 indicates above-average volatility compared to the broader market.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections